Related references
Note: Only part of the references are listed.Neutrophil or platelet-to-lymphocyte ratios in blood are associated with poor prognosis of pulmonary large cell neuroendocrine carcinoma
Minxing Shi et al.
TRANSLATIONAL LUNG CANCER RESEARCH (2020)
Prognostic significance of blood inflammatory biomarkers NLR, PLR, and LMR in cancer-A protocol for systematic review and meta-analysis
Chellan Kumarasamy et al.
MEDICINE (2019)
C-Reactive Protein and Platelet-Lymphocyte Ratio as Potential Tumor Markers in Low-Alpha-Fetoprotein Hepatocellular Carcinoma
Asli Suner et al.
ONCOLOGY (2019)
Stage-Dependent Changes in Albumin, NLR, PLR, and AFR are Correlated with Shorter Survival in Patients with Gastric Cancer
Cuixia Liu et al.
CLINICAL LABORATORY (2019)
Determinant roles of gender and age on SII, PLR, NLR, LMR and MLR and their reference intervals defining in Henan, China: A posteriori and big-data-based
Xianchun Meng et al.
JOURNAL OF CLINICAL LABORATORY ANALYSIS (2018)
The future of blood-based biomarkers for the early detection of breast cancer
Sau Yeen Loke et al.
EUROPEAN JOURNAL OF CANCER (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018
J. Ferlay et al.
EUROPEAN JOURNAL OF CANCER (2018)
Prognostic value of systemic inflammatory markers and development of a nomogram in breast cancer
Uiju Cho et al.
PLOS ONE (2018)
The prognostic and predictive value of tumor-infiltrating lymphocytes and hematologic parameters in patients with breast cancer
Kwan Ho Lee et al.
BMC CANCER (2018)
Preoperative elevated neutrophil-to-lymphocyte ratio (NLR) and derived NLR are associated with poor prognosis in patients with breast cancer A meta-analysis
Junwu Duan et al.
MEDICINE (2018)
Usefulness of lymphocyte-to-monocyte, neutrophil-to-monocyte and neutrophil-to-lymphocyte ratios as prognostic markers in breast cancer patients treated with neoadjuvant chemotherapy
C. Marin Hernandez et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2018)
THE ROLE OF COMPLETE BLOOD COUNT PARAMETERS IN PATIENTS WITH COLORECTAL CANCER
Melih Solak Mekic et al.
ACTA CLINICA CROATICA (2018)
Combination of preoperative NLR, PLR and CEA could increase the diagnostic efficacy for I-III stage CRC
Hong-Xin Peng et al.
JOURNAL OF CLINICAL LABORATORY ANALYSIS (2017)
Platelet-lymphocyte ratio acts as an indicator of poor prognosis in patients with breast cancer
Yanyun Zhu et al.
ONCOTARGET (2017)
Pathologic Complete Response After Neoadjuvant Chemotherapy and Long-Term Outcomes Among Young Women With Breast Cancer
Laura Spring et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2017)
Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab
Stefan Diem et al.
LUNG CANCER (2017)
Pathogenetic significance and possibility as a therapeutic target of platelet derived growth factor
Yoko Ishii et al.
PATHOLOGY INTERNATIONAL (2017)
Epithelial-mesenchymal transition and inflammation at the site of the primary tumor
Charli Dominguez et al.
SEMINARS IN CANCER BIOLOGY (2017)
Mechanisms that drive inflammatory tumor microenvironment, tumor heterogeneity, and metastatic progression
Li Yang et al.
SEMINARS IN CANCER BIOLOGY (2017)
The lymphocyte-monocyte ratio predicts tumor response and survival in patients with locally advanced esophageal cancer who received definitive chemoradiotherapy
Xuemei Liu et al.
ONCOTARGETS AND THERAPY (2017)
Prognostic performance of pre-treatment NLR and PLR in patients suffering from osteosarcoma
Wen-Kai Xia et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2016)
Neutrophils in cancer: neutral no more
Seth B. Coffelt et al.
NATURE REVIEWS CANCER (2016)
Platelets at the interface of thrombosis, inflammation, and cancer
Aime T. Franco et al.
BLOOD (2015)
Utility of pre-treatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio as prognostic factors in breast cancer
C-H Koh et al.
BRITISH JOURNAL OF CANCER (2015)
Elevated Platelet Count as Predictor of Recurrence in Rectal Cancer Patients Undergoing Preoperative Chemoradiotherapy Followed by Surgery
Yuji Toiyama et al.
INTERNATIONAL SURGERY (2015)
The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014
R. Salgado et al.
ANNALS OF ONCOLOGY (2015)
The Peripheral Blood Neutrophil-To-Lymphocyte Ratio Is Superior to the Lymphocyte-To-Monocyte Ratio for Predicting the Long-Term Survival of Triple-Negative Breast Cancer Patients
Weijuan Jia et al.
PLOS ONE (2015)
The elevated preoperative platelet-to-lymphocyte ratio predicts poor prognosis in breast cancer patients
S. Krenn-Pilko et al.
BRITISH JOURNAL OF CANCER (2014)
The value of the pretreatment neutrophil lymphocyte ratio vs. platelet lymphocyte ratio in predicting the long-term survival in colorectal cancer
Basem Azab et al.
CANCER BIOMARKERS (2014)
The prognostic value of preoperative NLR, d-NLR, PLR and LMR for predicting clinical outcome in surgical colorectal cancer patients
Hou-Qun Ying et al.
MEDICAL ONCOLOGY (2014)
Tracking of intertissue migration reveals the origins of tumor-infiltrating monocytes
Francis H. W. Shand et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Transforming Growth Factor-Beta and Matrix Metalloproteinases: Functional Interactions in Tumor Stroma-Infiltrating Myeloid Cells
Jelena Krstic et al.
SCIENTIFIC WORLD JOURNAL (2014)
Prognostic value of preoperative inflammatory markers in Chinese patients with breast cancer
Minya Yao et al.
ONCOTARGETS AND THERAPY (2014)
Pretreatment neutrophil/lymphocyte ratio is superior to platelet/lymphocyte ratio as a predictor of long-term mortality in breast cancer patients
Basem Azab et al.
MEDICAL ONCOLOGY (2013)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Share Paper
